(24 October 2022) NHS colleagues from across our region shared genomic advances in cancer, rare disease, heart disease and feto-maternal care at the National NHS Genomics Healthcare Summit on 12th October.
The event, held in London, was an opportunity for NHS colleagues, industry partners and others to explore how genomic medicine is improving outcomes for patients in our region and beyond.
The NHS North East and Yorkshire Genomic Medicine Service provided presentations on:
- National Nursing and Midwifery Genomics Transformation Programme, which is enabling nurses and midwives to deliver quality assured genomic services (Dr Naomi Chapman)
- Using systematic searching of medical records to identify patients at risk of Familial Hypercholesterolemia (FH) in Primary Care (Dr Judith Hayward)
- Evaluation of the Clinical Utility of Optical Genomic Mapping in Diagnostic NHS Genomics (Gavin Cuthbert)
Delegates visiting our stand were also able to explore how we’re transforming feto-maternal pathways to reduce inequity of access to genomic testing.
By embedding genomics into everyday healthcare, we can deliver faster and more accurate diagnoses, personalised treatment, and prevention through early detection.
National Nursing and Midwifery Genomics Transformation Programme
Led by the NHS North East and Yorkshire Genomic Medicine Service Alliance (GMSA), the National Nursing and Midwifery Genomics Transformation Programme is enabling nurses and midwives to deliver quality assured genomic services by:
- Driving the integration of genomics across nursing and midwifery practice in the NHS in England
- Developing and improving selected care pathways for cancers, rare diseases, and specific areas of midwifery practice